GT199800049A - METHOD FOR OBTAINING VHI PROTEASE INHIBITORS. - Google Patents

METHOD FOR OBTAINING VHI PROTEASE INHIBITORS.

Info

Publication number
GT199800049A
GT199800049A GT199800049A GT199800049A GT199800049A GT 199800049 A GT199800049 A GT 199800049A GT 199800049 A GT199800049 A GT 199800049A GT 199800049 A GT199800049 A GT 199800049A GT 199800049 A GT199800049 A GT 199800049A
Authority
GT
Guatemala
Prior art keywords
compounds
vhi
obtaining
protease inhibitors
hiv
Prior art date
Application number
GT199800049A
Other languages
Spanish (es)
Inventor
Kim ALBIZATI
Siegfried Reich
Michael D Varney
Kanyin E Zhang
Takuo Kobayashi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199800049A publication Critical patent/GT199800049A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LOS INHIBIDORES DE LA PROTEASA DEL VIH, OBTENIBLES POR SINTESIS QUIMICA, INHIBEN O BLOQUEAN LA ACTIVIDAD BIOLOGICA DE LA ENZIMA DE LA PROTEASA DEL VIH, HACIENDO QUE TERMINE LA REPLICACION DEL VIRUS DEL VIH. ESTOS COMPUESTOS, ASI COMO LAS COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y OPCIONALMENTE OTROS AGENTES ANTIVIRICOS COMO INGREDIENTES ACTIVOS, SON APTOS PARA TRATAR A PACIENTES O HUESPEDES INFECTADOS CON EL VIRUS DEL VIH, QUE SE CONOCE COMO CAUSA DEL SIDA. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA QUE SE PRESENTA A CONTINUACION, EN LA R Y R1, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.INHIBITORS OF HIV PROTEASE, OBTAINABLE BY CHEMICAL SYNTHESIS, INHIBIT OR BLOCK THE BIOLOGICAL ACTIVITY OF THE HIV PROTEASE ENZYME, CAUSING THE REPLICATION OF HIV VIRUSES TO END. THESE COMPOUNDS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND OPTIONALLY OTHER ANTIVIRIC AGENTS AS ACTIVE INGREDIENTS, ARE SUITABLE FOR TREATING PATIENTS OR GUESTS INFECTED WITH HIV VIRUSES, WHICH ARE KNOWN AS AIDS CAUSES. THESE COMPOUNDS HAVE THE CHEMICAL STRUCTURE BELOW, IN THE R AND R1, THEY ARE FUNCTIONAL GROUPS DESCRIBED IN THE FILE.

GT199800049A 1997-03-13 1998-03-12 METHOD FOR OBTAINING VHI PROTEASE INHIBITORS. GT199800049A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81559197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
GT199800049A true GT199800049A (en) 1999-09-03

Family

ID=47043826

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800049A GT199800049A (en) 1997-03-13 1998-03-12 METHOD FOR OBTAINING VHI PROTEASE INHIBITORS.

Country Status (1)

Country Link
GT (1) GT199800049A (en)

Similar Documents

Publication Publication Date Title
ES2181725T3 (en) HIV PROTEASA INHIBITORS.
KR980000447A (en) Pharmaceutical composition consisting of mirtazapine and one or more selective serotonin reuse inhibitors
PA8547501A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS
ES2152222T3 (en) SULFONAMIDS, ITS PREPARATION AND ITS USE AS MEDICINAL AND INTERMEDIATE.
ES2171670T3 (en) SULFONAMIDS CONTAINING OXYGEN HETEROCICLES AS INHIBITORS OF THE ASPARTIL PROTEASA.
DE60029799D1 (en) COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE
GT199800128A (en) 2-AMINOPYRIDINES CONTAINING SUBSTITUTES FOR CONDENSED RINGS.
PE20060149A1 (en) PHARMACEUTICAL FORMULATION TO TREAT HIV INFECTION
ATE257386T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF SELF-CROSS-LINKED AND NON-SELF-CROSS-LINKED HYALURONIC ACID FOR THE TREATMENT OF ARTHROPATHIES
PA8429901A1 (en) ANTIPICORNAVIRAL COMPOUNDS AND METHODS FOR USE AND PREPARATION
Kwon et al. Non-thermal atmospheric pressure plasma increased mRNA expression of growth factors in human gingival fibroblasts
BR9910573A (en) Antipicornoviral compounds, preparation and use thereof
ES2151600T3 (en) DERIVATIVES OF N- (3-AMINO-2-HYDROXIBUTE) SULFONAMIDE USED AS HIV PROTEASE INHIBITORS.
Lucas Two new marine species of Paraphysomonas
ATE328074T1 (en) OLIGONUCLEOTIDES CONTAINING AN ANTISENSE SEQUENCE STABILIZED BY A SECONDARY STRUCTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR0114082A (en) Compounds, pharmaceutical compositions, use of one or more compounds, and process for the manufacture of pharmaceutical compositions
BR0112614A (en) Compounds, pharmaceutical compositions, use of one or more compounds and process for the manufacture of pharmaceutical compositions
GT199800049A (en) METHOD FOR OBTAINING VHI PROTEASE INHIBITORS.
PA8448801A1 (en) HIV PROTEASE INHIBITORS
AR126239A1 (en) REGION 5 UNTRANSLATED AND REGION 3 UNTRANSLATED NON-NATURAL AND USE OF THESE
ECSP982442A (en) HIV PROTEASE INHIBITORS
ES2076248T3 (en) SUBSTITUTED DIBENZOFURANES AND METHODS FOR THE USE OF THEM.
FR2809725B1 (en) PROPANOLAMINOTETRALINS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
ES2156492B1 (en) PROCEDURE FOR OBTAINING MODIFIED SEPIOLITES AND USE OF SEPIOLITES IN OBTAINING SEMIOCHEMICAL ISSUERS WITH CONTROLLED EMISSION SPEED.
AR018297A1 (en) USE OF A D1 / D5 ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT OBSESSIVE COMPULSIVE DISORDERS, SOMATOFORM DISORDERS, DISTOCIATIVE DISORDERS, EAT DISORDERS, PULSE CONTROL AND AUTISM DISORDERS